Devicare has signed an agreement with the company Inmave to market the family of Lit-Control® products in Colombia for the domiciliary control of frequent urological pathologies. Colombia is the second American country and the fourth globally, after Spain, Mexico and France, to distribute this first-in-class method.

The two companies have begun the regulation process with the Colombian National Institute for Medicine and Food Surveillance (INVIMA) with the support of ACCIÓ de Bogotá's office. Lit-Control® is expected to reach patients at the end of 2017.

"Colombia has renowned professionals, but lacks innovative medical technology,” explains Miquel González-Mut, International Business Development Manager at Devicare. The country's government is aware of the problem and has promoted a renewal process of the health system aimed at relieving pressure and personalising treatment with actions such as opening 40 Primary Healthcare Facilities in Bogotá. The introduction of Lit-Control® fits perfectly with the state goals.

More information is available on Devicare's website

Photo: Miquel González-Mut and Rosendo Garganta of Devicare with Inmave - © Devicare